Huo, Bright https://orcid.org/0000-0003-4999-4328
Arezzo, Alberto
Sochorova, Dana
Boyle, Amy
Tryliskyy, Yegor
Ntaga, Iro
Mavridis, Dimitris
Adamina, Michel
Sylla, Patricia
Jiménez-Rodriguez, Rosa
Ntourakis, Dimitris
Popa, Dorin
Dulskas, Audrius
Gourtsoyianni, Sofia
Villanacci, Vincenzo
Florez, Ivan D.
Antoniou, Stavros A.
Funding for this research was provided by:
European Association for Endoscopic Surgery and other Interventional Techniques
European Society of Coloproctology
Article History
Received: 4 August 2025
Accepted: 14 November 2025
First Online: 18 December 2025
Change Date: 12 January 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00464-025-12530-6
Declarations
:
: Bright Huo, Alberto Arezzo, Dana Sochorova, Amy Boyle, Yegor Tryliskyy, Iro Ntaga, Dimitris Mavridis, Michel Adamina, Patricia Sylla, Rosa Jiménez-Rodriguez, Dimitris Ntourakis, Dorin Popa, Audrius Dulskas, Suzanne Doré, Raphaela Reeb-Ilgenfritz, Sofia Gourtsoyianni, Vincenzo Vilanacci, Ivan D. Florez, and Stavros A. Antoniou declare no direct conflicts of interest related to this work. Indirect conflicts of external advisors were documented and managed as per Guidelines International Network Standards. Detailed conflict of interest statements of all contributors can be found in the online appendix [ ].
: Not applicable.
: Not applicable.
: This clinical practice guideline has been developed under the auspice of the European Association for Endoscopic Surgery (EAES). It is intended to be used primarily by health professionals (e.g., surgeons, anesthetists, physicians) and to assist in making informed clinical decisions on diagnostic measures and therapeutic management. It is also intended to inform individual practice of allied health professionals (e.g., surgical nurses, dieticians, physical rehabilitation therapists, psychologists); to inform strategic planning and resource management by healthcare authorities (e.g., regional and national authorities, healthcare institutions, hospital administration authorities); and to inform patients wishing to obtain an overview of the condition of interest and its management. The use of recommendations contained herein must be informed by supporting evidence accompanying each recommendation and by research evidence that might not have been published by the time of writing the present document. Users must thus base their actions informed by newly published evidence at any given point in time. The information in the guideline should not be relied upon as being complete or accurate, nor should it be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. With the rapid development of scientific knowledge, new evidence may emerge between the time the guideline is developed and when it is published or read. The guideline is not continually updated and may not reflect the most recent evidence. The guideline addresses only the topics specifically identified therein and is not applicable to other interventions, diseases, or stages of diseases.This guideline does not mandate any particular course of medical care. Further, the guideline is not intended to substitute the independent professional judgment of the treating provider, as the guideline does not necessarily account for individual variation among patients. Even if evidence on a topic suggests a specific diagnostic and/or treatment action, users and especially health professionals may need to decide against the suggested or recommended action in view of circumstances related to patient values, preferences, co-morbidities and disease characteristics; available human, financial and material resources; and healthcare infrastructures. EAES provides this guideline on an “as is” basis, and makes no warranty, express or implied, regarding the guideline.